AstraZeneca PLC shares in demand after HSBC upgrade
Nudging up the valuation by 140p to 7,260p each, the bank said the main oncology pillars of the group – Lynparza,…
Read More...
Read More...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.
We respect your privacy and take protecting it seriously
Recover your password.
A password will be e-mailed to you.